Perspective: Who dares, wins

Bibi Bielekova ()
Additional contact information
Bibi Bielekova: Bibi Bielekova is an investigator in the Neuroimmunological Diseases Unit at the Intramural Research Program of the US National Institute of Neurological Disorders and Stroke in Bethesda, Maryland, which supports her research programme.

Nature, 2016, vol. 540, issue 7631, S10-S10

Abstract: It is time for a bolder approach to developing drugs for progressive multiple sclerosis, says Bibi Bielekova.

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/540S10a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:540:y:2016:i:7631:d:10.1038_540s10a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/540S10a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().